查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1716924

2025年生物反应器全球市场报告

Bioreactors Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年生物反应器市场规模将快速成长。到 2029 年，这一数字将成长至 185.8 亿美元，复合年增长率为 14.9%。预测期内的预期成长可归因于生物技术研究投资增加、慢性病盛行率上升、疫苗和治疗性蛋白质需求增加、生物製造监管支持增加以及先进疗法使用增加等因素。这段时期的主要趋势包括生物技术的进步、自动化和控制系统的改进、生物製程开发的成长、製造效率的提高以及对可扩展生产解决方案的需求的不断增加。

预计未来几年生物製药需求的不断增长将推动生物反应器市场的成长。生物製药是生物来源的治疗产品，用于预防、治疗或控制多种疾病。这种不断增长的需求是由医学研究的进步、个人化医疗的兴起以及对创新治疗的需求所推动的，有助于改善全球医疗保健结果。生物反应器透过实现治疗产品的高效和可扩展生产，在生物製药领域发挥着至关重要的作用。我们确保始终如一的质量，降低製造成本，并支持创新、改变生活的药物的开发。例如，美国工业协会美国药品研究与製造商协会2024年5月的数据显示，预计2022年美国生物製药产业总产出将超过1.65兆美元，其中直接生产产出8,000亿美元，供应商及相关部门产出8,000亿美元，占美国经济的3.6%。因此，对生物製药的需求不断增长正在推动生物反应器市场的成长。

生物反应器市场的主要企业正专注于创造固定台生物反应器等创新解决方案，以适应更复杂的生物培养物的生长。固定台生物反应器采用固体支撑结构，通常由珠子、纤维或颗粒等多孔材料製成，生物体附着在其上。这种设计改善了质量传递，降低了剪切应力，并可以更好地控制生物过程。例如，2024 年 10 月，比利时生物技术公司 Univercells Technologies 推出了其 Scale-X Nexo 生物反应器。这款先进的生物反应器的生长表面为 0.5 平方米，专为优化细胞培养过程开发而设计，为生物製药公司和研究实验室提供显着优势。 Scale-X Nexo 可无缝扩展到更大的模型，减少培养基和试剂的使用，与传统的入门级生物反应器相比，可将营运成本降低高达 60%。此外，它与 Skaia Vision 应用软体集成，无需直接采样即可估算准确的细胞数量，从而提高生产率。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情境 宏观经济情境包括利率、通货膨胀、地缘政治以及感染疾病和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球生物反应器 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球生物反应器市场：成长率分析
  • 全球生物反应器市场表现：规模与成长，2019-2024
  • 全球生物反应器市场预测：规模与成长，2024-2029，2034
  • 全球生物反应器总目标市场（TAM）

第六章市场区隔

  • 全球生物反应器市场（依生物製程类型、性能及预测），2019-2024 年、2024-2029 年、2034 年
  • 分批和补料分批
  • 经常使用
  • 全球生物反应器市场（按细胞类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 哺乳动物细胞
  • 细菌细胞
  • 酵母菌细胞
  • 其他细胞
  • 全球生物反应器市场控制、性能及预测（2019-2024、2024-2029、2034）
  • 手动的
  • 自动的
  • 全球生物反应器市场应用、性能及预测（2019-2024、2024-2029、2034）
  • 实验室规模生产
  • 中试规模生产
  • 全面生产
  • 全球生物反应器市场最终用途、性能及预测（2019-2024、2024-2029、2034）
  • 研发（R&D）组织
  • 生物製药製造商
  • 契约製造组织（CMO）
  • 全球生物反应器市场，批量和补料批量细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 传统批量生物反应器
  • 补料分批生物反应器
  • 全球生物反应器市场，按类型、性能和预测的连续细分，2019-2024 年、2024-2029 年、2034 年
  • 灌註生物反应器
  • 传统搅拌釜式生物反应器（CSTR）

第七章 区域和国家分析

  • 全球生物反应器市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球生物反应器市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 生物反应器市场：竞争格局
  • 生物反应器市场：公司简介
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • GE HealthCare Technologies Inc.
    • Cytiva Bioscience Holding Ltd.

第31章 其他大型创新企业

  • Sartorius AG
  • Cellexus Ltd.
  • Getinge AB
  • Eppendorf AG
  • ZETA Holding
  • Pierre Guerin
  • Broadley-James Corporation
  • PBS BIoTech Inc.
  • TAP Biosystems
  • Solida BIoTech GmBH
  • BBI-BIoTech GmbH
  • HiTec Zang GmbH
  • Xiamen Ollital Technology Co. Ltd.
  • Bioengineering AG
  • Infors AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年生物反应器市场：提供新机会的国家
  • 2029年生物反应器市场：细分领域带来新机会
  • 2029年生物反应器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33651

A bioreactor is a specialized system designed to maintain optimal conditions for biological processes, supporting the growth and function of cells, microorganisms, or enzymes. It ensures suitable environmental factors, including temperature, pH, oxygen, and nutrient supply, to enable desired biochemical reactions. Bioreactors are commonly utilized in industries such as pharmaceuticals, food production, and wastewater treatment.

The primary types of bioprocesses used in bioreactors are batch, fed-batch, and continuous. Bioreactors can support both batch and fed-batch processes, offering flexibility in optimizing production based on the complexity of the product and required yields. They are used with various cell types, including mammalian, bacterial, and yeast cells, and incorporate different control methods, such as manual and automated systems. Bioreactors are employed in applications ranging from lab-scale and pilot-scale production to full-scale production, serving end users such as research and development (R&D) organizations, biopharmaceutical manufacturers, and contract manufacturing organizations (CMOs).

The bioreactors market research report is one of a series of new reports from The Business Research Company that provides bioreactors market statistics, including the bioreactors industry global market size, regional shares, competitors with the bioreactors market share, detailed bioreactors market segments, market trends, and opportunities, and any further data you may need to thrive in the bioreactors industry. These bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioreactors market size has grown rapidly in recent years. It will grow from $9.22 billion in 2024 to $10.64 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth observed during the historic period can be attributed to several factors, including the increasing demand for biopharmaceuticals, the rise in cell and gene therapy research, a growing focus on personalized medicine, the adoption of single-use bioreactor technology, and the need for more efficient manufacturing processes.

The bioreactors market size is expected to see rapid growth in the next few years. It will grow to $18.58 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth anticipated during the forecast period can be attributed to factors such as increased investment in biotechnology research, the rising prevalence of chronic diseases, growing demand for vaccines and therapeutic proteins, enhanced regulatory support for biomanufacturing, and the increasing use of advanced therapies. Key trends for this period include advancements in biotechnology, improvements in automation and control systems, growth in bioprocess development, enhancements in manufacturing efficiency, and a rising need for scalable production solutions.

The rising demand for biopharmaceuticals is anticipated to drive the growth of the bioreactors market in the coming years. Biopharmaceuticals are therapeutic products derived from biological sources, including proteins, cells, and living organisms, used to prevent, treat, or manage various diseases. This growing demand is fueled by advancements in medical research, the rise of personalized medicine, and the need for innovative treatments, which contribute to improved healthcare outcomes globally. Bioreactors play a crucial role in the biopharmaceutical sector by enabling the efficient and scalable production of therapeutic products. They ensure consistent quality, lower production costs, and support the development of innovative, life-changing medicines. For example, in May 2024, data from Pharmaceutical Research and Manufacturers of America, a U.S.-based trade association, revealed that the U.S. biopharmaceutical industry generated over $1.65 trillion in total output in 2022, including $800 billion from direct production and another $800 billion from suppliers and related sectors, representing 3.6% of the U.S. economy. Consequently, the increasing demand for biopharmaceuticals is fueling the growth of the bioreactors market.

Leading companies in the bioreactors market are focusing on creating innovative solutions, such as fixed-bed bioreactors, to accommodate the growth of more complex biological cultures. Fixed-bed bioreactors utilize a solid support structure, often made from porous materials such as beads, fibers, or granules, to which biological organisms adhere. This design improves mass transfer, reduces shear stress, and offers better control over biological processes. For example, in October 2024, Univercells Technologies, a biotechnology company based in Belgium, introduced the Scale-X Nexo bioreactor. This advanced bioreactor, with a 0.5 m2 growth surface, is tailored to optimize cell culture process development, delivering significant advantages for biopharmaceutical companies and research organizations. The Scale-X Nexo enables seamless scalability to larger models, reduces media and reagent usage, and can cut operational costs by up to 60% compared to conventional entry-level bioreactors. Furthermore, it integrates with Skaia Vision application software, enhancing productivity by providing accurate cell count estimates without requiring direct sampling.

In December 2022, MilliporeSigma, a U.S.-based life sciences organization, acquired Erbi Biosystems Inc. for an undisclosed sum. This acquisition aims to enhance MilliporeSigma's upstream portfolio for therapeutic proteins by incorporating Erbi Biosystems' advanced 2 ml micro-bioreactor technology. The integration supports scalable, automated perfusion cell culture processes and accelerates the creation of life-enhancing therapeutics. Erbi Biosystems Inc., a U.S.-based biotechnology firm, specializes in the development of micro-bioreactor systems for optimizing cell culture and bioprocesses.

Major players in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, Broadley-James Corporation, PBS Biotech Inc., TAP Biosystems, Solida Biotech GmBH, BBI-Biotech GmbH, HiTec Zang GmbH, Xiamen Ollital Technology Co. Ltd., Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, and Shanghai Ritai Medicine Equipment Project Co. Ltd.

North America was the largest region in the bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bioreactors report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioreactors market consists of sales of stirred-tank bioreactors (STRs), airlift bioreactors, bubble column bioreactors, and packed-bed bioreactors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioreactors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioreactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioreactors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioreactors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Bioprocess: Batch And Fed-Batch; Continuous
  • 2) By Cell: Mammalian Cells; Bacterial Cells; Yeast Cells; Other Cells
  • 3) By Control: Manual; Automated
  • 4) By Usage: Lab Scale Production; Pilot Scale Production; Full Scale Production
  • 5) By End-Use: Research And Development (R&D) Organizations; Biopharmaceutical (Biopharma) Manufacturers; Contract Manufacturing Organizations (CMOS)
  • Subsegments:
  • 1) By Batch And Fed-Batch: Traditional Batch Bioreactors; Fed-Batch Bioreactors
  • 2) By Continuous: Perfusion Bioreactors; Continuous Stirred Tank Bioreactors (CSTR)
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE HealthCare Technologies Inc.; Cytiva Bioscience Holding Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioreactors Market Characteristics

3. Bioreactors Market Trends And Strategies

4. Bioreactors Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bioreactors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bioreactors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bioreactors Market Growth Rate Analysis
  • 5.4. Global Bioreactors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bioreactors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bioreactors Total Addressable Market (TAM)

6. Bioreactors Market Segmentation

  • 6.1. Global Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Batch And Fed-Batch
  • Continuous
  • 6.2. Global Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Other Cells
  • 6.3. Global Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual
  • Automated
  • 6.4. Global Bioreactors Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lab Scale Production
  • Pilot Scale Production
  • Full Scale Production
  • 6.5. Global Bioreactors Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research And Development (R&D) Organizations
  • Biopharmaceutical (Biopharma) Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • 6.6. Global Bioreactors Market, Sub-Segmentation Of Batch And Fed-Batch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Batch Bioreactors
  • Fed-Batch Bioreactors
  • 6.7. Global Bioreactors Market, Sub-Segmentation Of Continuous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Perfusion Bioreactors
  • Continuous Stirred Tank Bioreactors (CSTR)

7. Bioreactors Market Regional And Country Analysis

  • 7.1. Global Bioreactors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bioreactors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioreactors Market

  • 8.1. Asia-Pacific Bioreactors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioreactors Market

  • 9.1. China Bioreactors Market Overview
  • 9.2. China Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioreactors Market

  • 10.1. India Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioreactors Market

  • 11.1. Japan Bioreactors Market Overview
  • 11.2. Japan Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioreactors Market

  • 12.1. Australia Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioreactors Market

  • 13.1. Indonesia Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioreactors Market

  • 14.1. South Korea Bioreactors Market Overview
  • 14.2. South Korea Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioreactors Market

  • 15.1. Western Europe Bioreactors Market Overview
  • 15.2. Western Europe Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioreactors Market

  • 16.1. UK Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioreactors Market

  • 17.1. Germany Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioreactors Market

  • 18.1. France Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioreactors Market

  • 19.1. Italy Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioreactors Market

  • 20.1. Spain Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioreactors Market

  • 21.1. Eastern Europe Bioreactors Market Overview
  • 21.2. Eastern Europe Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioreactors Market

  • 22.1. Russia Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioreactors Market

  • 23.1. North America Bioreactors Market Overview
  • 23.2. North America Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioreactors Market

  • 24.1. USA Bioreactors Market Overview
  • 24.2. USA Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioreactors Market

  • 25.1. Canada Bioreactors Market Overview
  • 25.2. Canada Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioreactors Market

  • 26.1. South America Bioreactors Market Overview
  • 26.2. South America Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioreactors Market

  • 27.1. Brazil Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioreactors Market

  • 28.1. Middle East Bioreactors Market Overview
  • 28.2. Middle East Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioreactors Market

  • 29.1. Africa Bioreactors Market Overview
  • 29.2. Africa Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioreactors Market Competitive Landscape And Company Profiles

  • 30.1. Bioreactors Market Competitive Landscape
  • 30.2. Bioreactors Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cytiva Bioscience Holding Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Bioreactors Market Other Major And Innovative Companies

  • 31.1. Sartorius AG
  • 31.2. Cellexus Ltd.
  • 31.3. Getinge AB
  • 31.4. Eppendorf AG
  • 31.5. ZETA Holding
  • 31.6. Pierre Guerin
  • 31.7. Broadley-James Corporation
  • 31.8. PBS Biotech Inc.
  • 31.9. TAP Biosystems
  • 31.10. Solida Biotech GmBH
  • 31.11. BBI-Biotech GmbH
  • 31.12. HiTec Zang GmbH
  • 31.13. Xiamen Ollital Technology Co. Ltd.
  • 31.14. Bioengineering AG
  • 31.15. Infors AG

32. Global Bioreactors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioreactors Market

34. Recent Developments In The Bioreactors Market

35. Bioreactors Market High Potential Countries, Segments and Strategies

  • 35.1 Bioreactors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bioreactors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bioreactors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer